Business Daily Media

Men's Weekly

.

ZEISS Adopts PolyU's Patented Technology to Develop ZEISS MyoCare Myopia Control Lenses for Children

Professional ophthalmic products feature patented myopia control technology, effectively slowing down myopia progression in nearly 90% of child wearers

HONG KONG SAR - Media OutReach Newswire - 30 July 2024 - ZEISS Vision Care (ZEISS) and the School of Optometry of The Hong Kong Polytechnic University (PolyU) announced their latest collaborative initiative, ZEISS MyoCare Myopia Control Spectacle Lenses (ZEISS MyoCare Lenses).

The lenses utilize PolyU's patented Defocus Incorporated Soft Contact (DISC) technology for myopia management. Through this collaboration, the two parties joined forces to drive better control and management of myopia in children globally. This collaboration has enabled ZEISS to adopt PolyU's patented DISC technology in its specialist optical products, integrating authoritative academic ophthalmic research with cutting-edge ophthalmological technology to provide the public with new effective professional vision care solutions.

ZEISS Vision Care (ZEISS) and the School of Optometry of The Hong Kong Polytechnic University (PolyU) announced their latest collaborative initiative, ZEISS MyoCare Lenses, featuring (From left to right) Prof. Kee Chea-su, Head, School of Optometry, PolyU; Prof. Christopher Chao, Vice President (Research and Innovation), PolyU; Mr. David Ferran, Vice president, Latin America, Iberia & Asia -C, Vision Care Business Group, ZEISS and Mr Jerome Chan, Siu Lung, Head of Vision Care SBU, Hong Kong & Macau, ZEISS.
ZEISS Vision Care (ZEISS) and the School of Optometry of The Hong Kong Polytechnic University (PolyU) announced their latest collaborative initiative, ZEISS MyoCare Lenses, featuring (From left to right) Prof. Kee Chea-su, Head, School of Optometry, PolyU; Prof. Christopher Chao, Vice President (Research and Innovation), PolyU; Mr. David Ferran, Vice president, Latin America, Iberia & Asia -C, Vision Care Business Group, ZEISS and Mr Jerome Chan, Siu Lung, Head of Vision Care SBU, Hong Kong & Macau, ZEISS.

ZEISS MyoCare Lenses uses PolyU's DISC technology[1], its patented design adds a set of specialized optical microstructures to the general refractive myopia correction optical structure. The two sets of optical structures are arranged alternately on the lens surface. The corrective area projects the image onto the retina, allowing the wearer to see a clear image, while the optical microstructures project another set of images in front of the retina, i.e., the "forward optical defocus" signal, utilizing the eye's natural emmetropization feedback mechanism to guide the eye and slow down the growth of the eyeball axis of myopic patients. The technology is completely non-invasive and has undergone multiple basic experiments and clinical verifications, proven to be safe, effective and without significant side effects.

ZEISS MyoCare Lenses also incorporate patented ZEISS C.A.R.E.® technology. It can effectively decelerate the rate of myopia progression by 48% to 63% and diminish axial length increase by 41% to 77%[2],[3]. Furthermore, these lenses provide wearers with clear vision regardless of viewing distance and direction, and are easy to adapt to, with over 95% of child wearers able to adapt to the lenses within three days[4],[5].

A recent 12-month research report shows that nearly 90% of children wearing ZEISS MyoCare Lenses experienced slow annual myopia progression, compared to 51% of children wearing single vision lenses experiencing fast progression[6]. Moreover, ZEISS MyoCare lenses slowed eye growth from that of a myopic eye to approach that of an emmetropic eye by nearly 70%[7].

Mitigating the Risk of Myopia Progression in Children with Parental Myopia
Research confirmed that genetic factors, such as having parents with myopia, increases a child's risk of developing myopia. However, a 12-month clinical study has shown that compared to wearing regular single vision lenses, using ZEISS MyoCare Lenses can effectively slow down myopia progression, even for children with myopic parents, who are especially at risk of developing myopia[8]. This indicates that these lenses can help parents with myopia reduce the increased risk of myopia development in their children, essentially breaking the cycle of worsening myopia each generation.

Professor Christopher Chao, Vice President (Research and Innovation) of The Hong Kong Polytechnic University, said, "PolyU has always been committed to promoting technology transfer. The DISC technology for myopia management is an excellent example to demonstrate how academic research can be transformed into effective industry solutions, offering an additional option in the market for those in need. It is a great pleasure to collaborate with ZEISS, a leading optical brand, to jointly strive for excellence in the development of myopia control for the benefit of community."

David Ferran, Head of LatAm, Iberia & Asia-C, Vision Care Business, ZEISS Group, added, "ZEISS has been working closely with PolyU for many years. Through this collaboration, we will jointly develop more innovative technologies, aiming to bring the best ophthalmological technology into vision correction solutions, collectively addressing the threat posed by myopia and promoting the well-being of children worldwide."

Calvin Kwan, President of The Hong Kong Optometric Association, said: "Myopia is a serious issue among Hong Kong children, and age six to 12 years old is the 'golden period' for myopia control. Parents should seize the opportunity to provide the best and most effective myopia control measures for their children, safeguarding their eye health and preventing the development of high myopia and other long-term eye health problems."

The Trusted Choice for Parents – Backed by Scientific Research
Parents' testimonials: "In this digital age, it is practically impossible to completely avoid exposing our children to electronic devices, especially with the widespread adoption of e-learning in schools. As parents, we want to provide the best protection for our children, ensuring they have healthy eyes to see the future more clearly and far. Aligned with the needs of the current era, the issue of myopia control in children is a key eye health concern that parents need to address."

Parents' selection criteria: "When it comes to selecting lenses for myopia control, the primary consideration is the effectiveness and whether it is supported by scientific research. Since the 'golden period' for children's myopia control is only about six years, if we are unable to select and use scientifically proven products in a timely manner, the effect of slowing down myopia progression will be greatly diminished, and the precious golden period from age six to 12 will be missed.

The ZEISS MyoCare Lenses are supported by real data, which not only gives me confidence in the product, but also allows me, through this myopia control solution, to work more closely with the optometrist to address my child's myopia progression. I believe parents play a very important role in protecting the eye health of their children."



[1] Hong Kong Polytechnic University owns granted patents (including Chinese patent: CN103097940) on annular concentric lens for myopia control, which are licensed to Carl Zeiss..

[2] Compared to ZEISS single vision lenses, after 12 months of wear, ZEISS MyoCare designs slowed myopia progression on average of 48% (MyoCare) and 45%(MyoCare S) for spherical equivalent error, and by 41%(MyoCare) and 34%(MyoCare S) for axial length. Chen, X., et al. (2024, May 5-9). Slowing myopia progression with cylindrical annular refractive elements (CARE) – 12-month interim results from a 2-year prospective multi-center trial [Conference presentation abstract]. The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Seattle, WA, United States.

[3] Compared to ZEISS single vision lenses, after 6 months of wear, ZEISS MyoCare slowed myopia progression on average of 0.15D (63%) for spherical equivalent error and 0.07mm (77%) for axial length. Alvarez-Peregrina, C., et al. (2024, May 5-9). Efficacy of a next-generation design of ophthalmic lenses for myopia control: Six-month results of the CEME Study [Conference presentation abstract]. The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Seattle, WA, United States.

[4] Rifai, K., et al. (2024, May 5-9). Subjective acceptance of spectacle lenses with cylindrical annular refractive elements (CARE) in Chinese children with myopia [Conference presentation abstract]. The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Seattle, WA, United States.

[5] Alvarez-Peregrina C., et al. (2024, April 12-14). Vision, confort y tiempo de adaptacion a un nuevo diseno de lente oftalmica para el control de miopia [Conference presentation abstract]. OPTOM 2024, Madrid, Spain.

[6] Sankaridurg, P., et al. (2024, May 5-9). Probability of surviving fast progression and eye growth reversal after 1-year of spectacle wear with cylindrical annular refractive elements [Conference presentation abstract]. The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Seattle, WA, United States.

[7] Twelve-months of lens wear, both ZEISS MyoCare lenses slowed AL significantly and approached closer to AL growth of an emmetropic eye, with average EPRs of 70%* for ZEISS MyoCare and 68% for ZEISS MyoCare S. Ohlendorf, A., et al. (2024, May 5-9). Myopia control efficacy through Emmetropic Progression Ratio:1-year of spectacle wear with cylindrical annular refractive elements (CARE) [Conference presentation abstract]. The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Seattle, WA, United States.

[8] Boeck-Maier, C., et al. (2024, May 5-9). Impact of parental myopia on myopia control efficacy of spectacle lenses with cylindrical annular refractive elements (CARE) [Conference presentation abstract]. The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Seattle, WA, United States.

Hashtag: #ZEISS #MyoCare

The issuer is solely responsible for the content of this announcement.

About ZEISS

With a rich history spanning 175 years, ZEISS is recognized as one of the oldest and most esteemed optical brands worldwide. Throughout the past century, ZEISS has consistently led the market, offering unparalleled optical products and expert knowledge. As a visionary and iconic brand, ZEISS has always prioritized precision in the production of optical lenses, striving to become a lifelong partner in vision care for individuals. ZEISS' commitment lies in empowering people to see the world with utmost clarity. ZEISS proved that everyone's visual world is unique and that ZEISS understands people and their individual needs like no one else. Let's unlock everyone's full potential with premium vision and eye care solutions by ZEISS.

About the School of Optometry of The Hong Kong Polytechnic University

The Hong Kong Polytechnic University (PolyU) aspires to be an innovative world-class university with a strong sense of social responsibility, driven by its motto, "To learn and to apply, for the benefit of mankind". The University provides the best holistic education to nurture socially responsible "leaders of tomorrow" who possess a strong sense of national identity and a global perspective, and pursues impactful innovation and interdisciplinary research to address the world's most pressing challenges. A robust culture of knowledge transfer and entrepreneurship is a cornerstone of the University, ensuring PolyU's technologies are transformed into practical real-world applications. The University's unwavering commitment to excellence has earned it international recognition, with PolyU consistently ranking among the top 100 universities worldwide. Based on this solid foundation, the University will continue to make positive contributions in collaboration with its strategic partners for the betterment of Hong Kong, the Nation, and the world.

The PolyU School of Optometry is the only institution in Hong Kong that offers a bachelor's honours degree programme in optometry leading to a professional qualification as an optometrist in Hong Kong and the programme is regarded as one of the best in the world. As a globally top-ranking optometry department for research excellence, the School strives to undertake research-based teaching of the highest academic standards and to contribute to the promotion and delivery of high-quality vision and eye care in Hong Kong and elsewhere.

News from Asia

Ice and Snow as a Bridge to Global Dialogue, Charting a New Chapter of Cooperative Development: the "Global Mayors Dialogue · Harbin" Kicked Off on January 6

HARBIN, CHINA - Media OutReach Newswire - 6 January 2026 - Using the city as a window to showcase China's opportunities and mayors as catalysts for exchanging governance insights, the "Global Mayo...

1win and MMA Legend Jon Jones Fulfill Over 100 Wishes in Global Holiday Initiative

WILLEMSTAD, CURAÇAO - Media OutReach Newswire - 6 January 2026 - 1win Charity, together with MMA legend Jon Jones, has successfully concluded its global campaign 1wish Season – a holiday initiati...

[CES 2026 Deep Dive] From Fingertips to the Stars: Lens Technology Debuts Aerospace-Grade UTG, Reshaping the LEO Satellite "Energy Canopy"

LAS VEGAS, UNITED STATES - Media OutReach Newswire - 7 January 2026 - Amidst a CES 2026 landscape dominated by AI headlines and humanoid robots, a quiet corner of the Lens Technology booth has une...

CP AXTRA Achieves 88/100 DJSI Sustainability Score Ranks 2nd Globally in the Food & Staples Retailing Sector, Reinforcing Its Global Leadership in Retail and Wholesale Sustainability

BANGKOK, THAILAND - Media OutReach Newswire - 7 January 2026 - CP AXTRA Public Company Limited (CP AXTRA), the operator of Asia's leading wholesaler and retailer "Makro and Lotus's," has achieved...

Changhong Unveils AI‑Powered Smart Home Solutions at CES 2026

LAS VEGAS, US - Media OutReach Newswire - 7 January 2026 - The 2026 International Consumer Electronics Show (CES 2026) opened on January 6 in Las Vegas, bringing together leading global technology...

Grab Acquires Chinese AI Robotics Firm Infermove to Strengthen Last-Mile Delivery Capabilities

NEW YORK, US - Media OutReach Newswire - 6 January 2026 - Singapore-based Grab Holdings Ltd. (NASDAQ: GRAB) announced on December 19th the acquisition of Infermove, a Chinese AI robotics company, ...

Prudential Study Reveals Young Asians Choose Financial Planning Over Spontaneity

71 per cent of Asia’s young adults prefer clear planning, with 69 per cent optimistic about their financial future despite prevailing uncertainty HONG KONG SAR - Media OutReach Newswire - 7 Januar...

Jorakay Corporation Appoints Dr. Jirat Sirichalermpong as New CEO, Effective January 5, 2026

BANGKOK, THAILAND - Media OutReach Newswire - 7 January 2026 - Jorakay Corporation Co., Ltd., Thailand's leading construction innovation company, has appointed Dr. Jirat Sirichalermpong as Chief...

Singapore fintech sees surge in investments despite global trade fragmentation and tariff escalation: KPMG’s Pulse of Fintech H1’25

SINGAPORE - Media OutReach Newswire - 26 September 2025 - Singapore's fintech sector recorded a strong rebound in the first half of 2025, attracting close to US$1.04 billion in investments across ...

KPMG and SID unveil Budget 2026 strategies to bolster Singapore’s role as a hub for global flows

Tackle rising business costs and trade barriers with a unified digital platform for Free Trade Agreements as well as build stronger economic partnerships.

Stop reading from the script: Why authenticity is the customer success secret weapon

I’ve been in customer service for years now. As my team has grown, the number one piece of advice I give is to be your...

From Check-in to Touchdown: How AI and smarter systems are transforming the travel industry

Richard Valente, VP of Customer Experience Strategy at TP in Australia, explores how IT-BPM outsourcing is revolutionising the travel sector throu...

Online Christmas shoppers fund climate and biodiversity projects via HealthPost's Click Sphere for Good initiative

Online shoppers with HealthPost’s Flora & Fauna have made 11,000 contributions towards climate and biodiversity projects when ordering parcel ...

US landmark settlement protects SMEs, highlighting flaws in the RBA's proposed blanket card surcharging ban for Australia

Aussie SMEs warn RBA not to ignore global trends, with the current sledgehammer approach threatening business viability and increasing inflation ...

Thryv Australia named Employer of Choice for third consecutive year at Australian Business Awards

Thryv® (NASDAQ: THRY), Australia’s provider of the leading small business marketing and sales software platform, has been awarded the Employer of ...

RogersDigital.com Announces the Launch of TheBulletin.au, a Destination for Business, Policy and Financial Insight

RogersDigital.com has announced the launch of TheBulletin.au, a new national digital publication designed to deliver sharp, data-driven reporting ...